Gjermund Johnsen

Dr. Gjermund Johnsen

St Olav's University Hospital, Trondheim, Sør-Trøndelag, Norway
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

27 August 2023 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
KBKirsti K. Bjerkan
Kirsti K. Bjerkan
JSJorunn Sandvik
Jorunn Sandvik
SNSiren Nymo
Siren Nymo
HGHalvor Græslie
Halvor Græslie
GJGjermund Johnsen
Gjermund Johnsen
DHDag Arne L. Hoff
Dag Arne L. Hoff
Purpose: Micronutrient deficiencies are common after Roux-en-Y gastric bypass (RYGB). This study explores whether vitamin and mineral deficiency was associated with adherence to recommended supplementation 12 years after RYGB. Materials and Methods: The cross-sectional Bariatric Surgery Observation Study (BAROBS) was conducted in 2018–2020 at three hospitals in Central Norway. We report data on 490 patients’ self-reported adherence to recommended supplements and vitamin and mineral levels in the blood. The patients, who had RYGB between 2003 and 2009, were recommended an over-the-counter multivitamin-mineral supplement, calcium/vitamin D (1000 mg/20 µg) and vitamin B12 injections (reimbursed), since bariatric supplements were not available then. Results: Mean (SD) age was 40.1 ± 9 years at RYGB, and time to follow-up 11.7 ± 1.6 years. Of 490 patients, 393 (80%) were women. Among 361 (74%) patients’ adherent to multivitamin-mineral supplements; folate, vitamin B2, and vitamin B6 deficiency were present in 39 (11%), 103 (29%), and 63 (17%) patients, respectively. The same deficiencies occurred in 44 (34%), 67 (52%), and 67 (52%) patients’ non-adherent to recommendations. Although 466 (95%) patients reported adherence to vitamin B12 supplements, sub-optimal levels were found in 73 (16%) patients. Though 336 (69%) patients adhered to calcium/vitamin D supplements (1000 mg/20 µg), sub-optimal vitamin D levels (< 75 nmol/l) were found in 174/336 (52%) adherent patients and 120/154 (78%) non-adherent patients. Conclusion: Twelve years after RYGB, adherence to supplements, though in sub-optimal doses of new recommendations, decreases the probability of vitamin and mineral deficiency, especially for thiamine, vitamin B2, vitamin B6, folate, vitamin B12, and vitamin D, but does not eliminate it. Graphical

3 July 2019 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
PSPer Even Storli
Per Even Storli
GJGjermund Johnsen
Gjermund Johnsen
IJIngebjørg S. Juel
Ingebjørg S. Juel
JGJon Erik Grønbech
Jon Erik Grønbech
EBErling A. Bringeland
Erling A. Bringeland
Background and aims: Expanded criteria for resection of colorectal liver metastases (CRLM) have led to a more aggressive surgical attitude. The aim is to evaluate any impact of expanded criteria on perioperative mortality and long-term survival. Materials and methods: A population based study from 2001 to 2015 for patients undergoing surgery for CRLM. The cohort was divided into three 5-year periods. Results: A total of 341 patients underwent resection of CRLM. Relative to the number of colorectal primaries, patients resected for CRLM increased from 82/2520 (3.3%) in 2001–2005 to 151/3071 (4.9%) in 2011–2015 (p = .007). The proportion of patients who underwent formal resections declined from 62% to 21%. There was a substantial increase in resections of synchronous liver metastases, portal vein embolizations, two-stage resections, and the share of octogenarians who underwent resection. The proportion of patients undergoing reresections of new liver recurrences increased from 6% to 24%. The 90-d postoperative mortality for 2001–2005, 2006–2010, and 2011–2015 were 7.9%, 0.8%, and 2.0%, respectively. The median overall survival was 47 months during the two first periods, for the last period not reached. The 5-year overall survival remained at 40% from 2001 to 2010, and estimated at 55.2% from 2011 to 2015. The 5-year disease-free survival was well above 30%. The 5-year overall survival following liver reresection was 52.6%. Conclusion: Postoperative mortality remained at approximately 2%, and the 5-year overall survival at 40% in the first 10 years, but increased to 55% in the last 5 years under study, despite a marked increase in resection rates.

21 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ESElfrid Christine Smith Sandvik
Elfrid Christine Smith Sandvik
KAKristin Matre Aasarød
Kristin Matre Aasarød
GJGjermund Johnsen
Gjermund Johnsen
DHDag Arne Lihaug Hoff
Dag Arne Lihaug Hoff
BKBård Kulseng
Bård Kulseng
RFReidar Fossmark
Reidar Fossmark
Severe obesity is a strong risk factor for non-alcoholic fatty liver disease (NAFLD). Roux-en-Y gastric bypass (RYGB) surgery effectively induces weight loss, but few studies have described the long-term effects of RYGB on NAFLD-related fibrosis. Data from 220 patients with severe obesity operated by RYGB in Central Norway were analysed. Variables incorporated in NAFLD Fibrosis Score (NFS), Fibrosis-4 (FIB-4) index and anthropometric data were collected before surgery and a mean of 11.6 years postoperatively. FIB-4 > 1.3 or NFS > 0.675 were used as cut-off values for advanced fibrosis. Proportions with advanced fibrosis decreased from 24% to 14% assessed by FIB-4 and from 8.6% to 2.3% using NFS, with resolution rates of advanced fibrosis of 42% and 73%, respectively. The shift towards lower fibrosis categories was significant (NFS p < 0.0001; FIB-4 p = 0.002). NFS decreased from −1.32 (IQR −2.33–−0.39) to −1.71 (IQR −2.49–−0.95, p < 0.001) 11.6 years after surgery, whereas FIB-4 did not change: 0.81 (IQR 0.59–1.25) to 0.89 (IQR 0.69–1.16, p = 0.556). There were weak correlations between change in fibrosis scores and weight loss. In conclusion, the majority of patients with advanced fibrosis at baseline had improvement after 11.6 years. Factors associated with reduction in fibrosis were not identified.

20 May 2011 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
PFPer G. Farup
Per G. Farup
IBIvar Blix
Ivar Blix
SFSigurd Førre
Sigurd Førre
GJGjermund Johnsen
Gjermund Johnsen
OLOve Lange
Ove Lange
HPHermod Petersen
Hermod Petersen
Optimal treatment gives complete relief of symptoms of many disorders. But even if such treatment is available, some patients have persisting complaints. One disorder, from which the patients should achieve complete relief of symptoms with medical or surgical treatment, is gastroesophageal reflux disease (GERD). Despite the fact that such treatment is cheap, safe and easily available; some patients have persistent complaints after contact with the health services. This study evaluates the causes of treatment failure.

4 June 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
ÅHÅsne Ask Hyldmo
Åsne Ask Hyldmo
DHDag Arne Lihaug Hoff
Dag Arne Lihaug Hoff
AWArne Wibe
Arne Wibe
KBKirsti Kverndokk Bjerkan
Kirsti Kverndokk Bjerkan
SNSiren Nymo
Siren Nymo
JSJorunn Sandvik
Jorunn Sandvik
Background: The knowledge on chronic abdominal pain and gastrointestinal (GI) symptoms as a long-term complication to Roux-en-Y gastric bypass (RYGB) is limited. The aim of this study was to explore the frequency and characteristics of chronic abdominal pain and GI symptoms long-term after primary RYGB compared to the general population. Methods: A cross-sectional study of patients 10–15 years after RYGB compared to a control group with a similar age and sex distribution from the HUNT4 Survey. Abdominal pain and GI symptoms were assessed with a self-reported questionnaire. Results: A total of 496 patients were included, with a mean observation time of 11.7 ± SD 1.6 years after RYGB. The controls were 3000 participants from HUNT4. Chronic abdominal pain was reported by 162 (32.7%) RYGB patients compared to 697 (23.2%) of the controls (p < 0.001). Bloating was the most common GI symptom reported by 356 (72%) RYGB patients. Eighty-two (16.5%) RYGB patients and 302 (10.1%) controls graded chronic pain as severe (p < 0.001). Severe chronic pain after RYGB was more often located in the upper part of the abdomen in 58 (71%) patients, associated with severe nausea in 27 (33%) patients, and less often relieved after defecation in 35 (42%) patients compared to the controls (p < 0.001). Conclusions: Twelve years after RYGB, a third of patients reported chronic abdominal pain compared with a quarter of controls. Half of the participants with chronic abdominal pain in both groups rated the pain as severe. The location of severe pain and associations with other gastrointestinal symptoms differed between the two groups. Graphical